ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CRDL Cardiol Therapeutics Inc

2.45
-0.05 (-2.00%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Cardiol Therapeutics Financial Summary

The current CRDL market cap is 160.11M. The company's latest EPS is CAD -0.4304 and P/E is -5.65.

Year End December 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 07k79k00
Operating Income -14.13M-20.68M-38.66M-41.34M-29.79M
Net Income -13.68M-20.64M-31.64M-30.93M-28.13M
Year End December 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 15.5M15.89M87.88M62.03M36.7M
Total Liabilities 831k2.62M11.64M9.83M8.45M
Total Equity 14.67M13.27M76.24M52.2M28.25M

Cash Flow

Year End December 30 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -11.38M-9.19M-23.55M-27.22M-25.18M
Investing -424k-41k-13k-75k-64k
Financing 2.03M16.3M93.44M-54k-55k
Market Cap 160.11M
Price to Earnings Ratio -5.65
Price to Sales Ratio 0
Price to Cash Ratio 4.55
Price to Book Ratio 5.62
Dividend Yield -

Share Statistics

Shares Outstanding 65.35M
Average Volume (1 week) 81.86k
Average Volume (1 Month) 87.5k
52 Week Change 178.41%
52 Week High 2.94
52 Week Low 0.74
Spread (Intraday) 0.05 (2%)

Company Info

Company Name Cardiol Therapeutics Inc
Address 2265 upper middle road east
oakville, ontario L6H 0C3
Website https://
Industry coml physical, biologcl resh (8731)

Your Recent History

Delayed Upgrade Clock